Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For MYH7 and TTN cohorts, must have diagnosis of primary DCM (dilated cardiomyopathy), clinically stable and due to probably disease-causing variant of MYH7 or TTN
Has adequate acoustic windows for echocardiography
Maximum of 3 family members with same variant can be enrolled
For the cohort of primary DCM due to causalities other than MYH7 and TTN, participant must have diagnosis of primary DCM with a cause not related to MYH7 or TTN variants
You may not be if
Significant structural cardiac abnormalities including valvar dysfunction on Screening transthoracic echo(s)
Routinely scheduled outpatient intravenous (IV) infusions for heart failure (e.g., inotropes, afterload reduction, or diuretics)
Presence of protocol specified laboratory abnormalities at Screening
Recent acute coronary syndrome or angina pectoris (\<90 days)
Recent hospitalization for heart failure (\<90 days)
Clareo Health | Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants or Other Causalities
